The Europe, the Middle East, and Africa (EMEA) Safety Lancet Market are encountering critical growth, driven by the rising emphasis on healthcare safety. With an emphasis on prevention needlestick wounds and lessening the risk of bloodborne contaminations, safety lancets are turning into a favored decision for blood testing in healthcare settings across the EMEA locale.
The high frequency of constant sicknesses in Europe, the Middle East, and Africa is adding to the demand for safety lancets. These gadgets assume an urgent part in usual blood glucose observing, cholesterol testing, and other demonstrative methodology fundamental for overseeing constant circumstances like diabetes and cardiovascular illnesses.
The rising pattern towards home healthcare is influencing the Safety Lancet Market. Patients are taking on safety lancets for self-checking, considering advantageous and standard blood examining in the comfort of their homes. This pattern lines up with the more extensive shift towards patient-centric care in the EMEA locale.
The EMEA Safety Lancet Market is seeing a developing spotlight on preventive healthcare. Safety lancets are utilized for analytic purposes as well as becoming necessary to preventive health check-ups, considering early recognition of conditions, and advancing proactive healthcare rehearses.
The dispersion landscape for safety lancets is advancing with the ascent of internet business and online retail channels. The comfort and directness of buying safety lancets online are adding to market growth, offering purchasers a more extensive scope of item choices and simplicity of procurement.
Makers are focusing in on creating safety lancets altered for pediatric applications. These gadgets address the extraordinary requirements of youngsters, giving a not so much invasive but rather more agreeable blood testing experience, thereby advancing consistency in pediatric patients.
Europe, The Middle East & Africa Safety Lancet market size was valued at USD 1.5 billion in 2023. The Europe, The Middle East & Africa Safety Lancet market industry is projected to grow from USD 1.8 billion in 2024 to USD 3.0 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.22% during the forecast period (2023 - 2032).
Increase in the prevalence of diabetes, and high growth prospects in emerging countries are propelling the growth of the market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The increasing incidences of diabetes worldwide are driving the growth of the safety lancet market. Safety lancets are used for blood glucose monitoring and medication administration in diabetic patients. As the prevalence of diabetes continues to rise, the demand for safety lancets is also increasing. Additionally, the growing awareness about the importance of regular monitoring of blood glucose levels in diabetic patients is contributing to the growth of the safety lancet market. Regular blood glucose monitoring is essential for managing diabetes and preventing complications, leading to a higher adoption of safety lancets among diabetic patients. For instance, according to the British Diabetic Association, about 73 million were diagnosed with diabetes in 2021, and 27 million adults were undiagnosed.
Moreover, advancements in technology have led to the development of safer and more user-friendly safety lancets, further fueling the growth of the market. These innovative products offer improved comfort and convenience for patients, encouraging more individuals to use safety lancets for blood glucose monitoring. Overall, the increasing prevalence of diabetes, rising awareness about the importance of blood glucose monitoring, and technological advancements in safety lancets are driving the growth of the safety lancet market.
The Europe, The Middle East & Africa Safety Lancet market segmentation, based on type, includes Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet. The Push Button Safety Lancet segment dominated the market in the base year, i.e., 2023, and is the fastest-growing segment during the forecast period, 2024–2032. This is due to the increased safety, and push-button mechanism often delivers a faster and more precise puncture, which some users find less painful than using a traditional lancet.
The Europe, The Middle East & Africa Safety Lancet market is segmented, based on end user, into Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others. The Hospitals & Clinics segment held the majority of the market and is the fastest-growing segment during the forecast year due to the growing demand for frequent glucose testing, hemoglobin testing, cholesterol testing, allergy testing, coagulation testing, and neonatal screening across the region is driving the growth of market.
FIGURE 2: Europe, The Middle East & Africa Safety Lancet, By End User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
By region, the study segments the market into Europe, and Middle East. In Safety Lancet market Europe held the largest market share in 2023 due to the increasing adoption of Safety Lancets in healthcare facilities and rising awareness about preventing needle-stick injuries among healthcare professionals. Additionally, the stringent regulatory guidelines pertaining to the safe disposal of medical waste have also contributed to the dominance of the Safety Lancet market in Europe. The market is expected to witness significant growth in the coming years, driven by increasing healthcare expenditure and technological advancements in Safety Lancet devices.
FIGURE 3: Europe, The Middle East & Africa Safety Lancet , By Region, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The Middle East & Africa Safety Lancet market accounted for the second-largest market share the increasing prevalence of chronic diseases such as diabetes, which require regular blood glucose monitoring. Additionally, Countries in the Middle East & Africa region, such as the UAE, Saudi Arabia, and South Africa, are focusing on improving their healthcare infrastructure and promoting the use of safety devices to enhance patient and healthcare worker safety. This, in turn, is expected to drive the demand for safety lancets in the region.
Furthermore, increasing healthcare expenditures, growing geriatric population, and rising demand for point-of-care testing are also expected to fuel market growth in the Middle East & Africa region. With advancements in technology and the development of innovative safety lancet products, the market is expected to continue to expand in the coming years.
Some of the key market players in the Eu, Middle East & Africa safety lancet market include Becton Dickinson and Company, Bayer AG, Terumo Corporation, HTL-STREFA, Sarstedt AG & Co., and Accu-Chek (Roche). These companies are continuously investing in research and development to develop innovative products and expand their product portfolio. They are also focusing on strategic collaborations, partnerships, and acquisitions to strengthen their market position and expand their geographic presence.
Competition in the safety lancet market is intense, with companies striving to differentiate their products through features such as ergonomic design, ease of use, and increased safety measures. In addition, there is a growing trend towards the development of technologically advanced safety lancets that provide improved comfort and reduced pain for patients.
Key Companies in the Europe, The Middle East & Africa Safety Lancet Market includes.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)